Arcadia Biosciences Inc. (RKDA)
2.67
-0.29 (-9.80%)
At close: Apr 02, 2025, 3:33 PM
Arcadia Biosciences Income Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
| Revenue | 5.04M | 5.33M | 9.96M | 6.78M | 8.03M | 1.17M | 1.46M | 4.03M | 3.19M | 5.41M | 6.98M | 6.48M | 7.01M |
| Cost of Revenue | 2.96M | 3.3M | 9.8M | 8.71M | 5.2M | 885K | 661K | 283K | 895K | 892K | 2M | 673K | 909K |
| Gross Profit | 2.08M | 2.03M | 154K | -1.93M | 2.83M | 284K | 803K | 3.74M | 2.29M | 4.52M | 4.99M | 5.8M | 6.1M |
| Operating Income | -3.65M | -13.87M | -19.4M | -35.53M | -21.59M | -20.38M | -16.87M | -14.31M | -18.62M | -15.56M | -15.15M | -10.57M | -10.13M |
| Interest Income | 782K | 695K | 289K | 20K | 47K | 5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -4.31M | -13.16M | -15.6M | -16.13M | -6.15M | -28.87M | -13.47M | -15.68M | -19.6M | -17.93M | -17.14M | -11.19M | -10.31M |
| Net Income | -7.04M | -13.98M | -15.61M | -16.13M | -6.03M | -28.87M | -13.48M | -15.71M | -19.62M | -17.96M | -18.34M | -13.2M | -12.37M |
| Selling & General & Admin | 9.64M | 14.51M | 18.05M | 22.94M | 16.47M | 13.57M | 11.6M | 10.65M | 12.25M | 11.12M | 10.13M | 7.97M | 8.28M |
| Research & Development | 53K | 1.39M | 1.51M | 3.89M | 7.96M | 7.1M | 6.07M | 7.41M | 8.66M | 8.97M | 10.01M | 8.4M | 7.95M |
| Other Expenses | -3.96M | n/a | 33K | 10.11M | 105K | 466K | -3.61M | 281K | 340K | 521K | n/a | 5K | 8K |
| Operating Expenses | 5.73M | 15.89M | 19.56M | 26.83M | 24.43M | 20.66M | 17.67M | 18.06M | 20.91M | 20.09M | 20.14M | 16.37M | 16.23M |
| Interest Expense | n/a | n/a | 289K | 20K | 47K | 5K | n/a | 747K | 1.32M | 2.66M | 1.39M | 626K | 186K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 8.69M | 19.2M | 29.36M | 35.53M | 29.63M | 21.55M | 18.33M | 18.34M | 21.81M | 20.98M | 22.14M | 17.04M | 17.14M |
| Income Tax | 8K | 8K | 14K | 2K | -124K | 2K | 10K | 26K | 25K | 26K | 263K | 167K | 213K |
| Shares Outstanding (Basic) | 1.36M | 1.24M | 599.39K | 532.01K | 248.97K | 159.08K | 94.16K | 53.91K | 55.46K | 35.7K | 40.9K | 40.9K | 40.9K |
| Shares Outstanding (Diluted) | 1.36M | 1.24M | 599.39K | 532.01K | 248.97K | 159.08K | 94.16K | 53.91K | 55.46K | 35.7K | 40.9K | 40.9K | 40.9K |
| EPS (Basic) | -5.16 | -11.3 | -26.05 | -30.33 | -24.2 | -181.5 | -143.16 | -291.38 | -353.85 | -503 | -448.39 | -322.62 | -302.44 |
| EPS (Diluted) | -5.16 | -11.3 | -26.05 | -30.33 | -24.2 | -181.5 | -143.16 | -291.38 | -353.85 | -503 | -448.39 | -322.62 | -302.44 |
| EBITDA | -7.5M | -13.58M | -13.65M | -23.27M | -5.44M | -28.67M | -13.32M | -14.65M | -17.98M | -14.98M | -15.39M | -10.17M | -9.74M |
| EBIT | -7.61M | -13.16M | -15.23M | -28.75M | -6.1M | -28.87M | -13.47M | -14.93M | -18.28M | -15.27M | -15.75M | -10.56M | -10.12M |
| Depreciation & Amortization | 113K | 287K | 1.36M | 1.04M | 662K | 194K | 154K | 279K | 304K | 294K | 358K | 391K | 378K |